- Headquarters: Rancho Cucamonga, CA
- Founded: 1996
- amphastar.com
Amphastar Pharmaceuticals received FDA approval of its ANDA for sodium bicarbonate injection 8.4% in 50 mL Luer-Jet Prefilled Syringe System
Net revenues for the company's sodium bicarbonate injection for the year ended December 31, 2016 were $5.9 million. The company continues to market five grandfathered products, (now termed "unapproved") and has ANDAs pending approval for three of these products. For the year ended December 31, 2016, the company recorded net revenues of $27.6 million from these unapproved products.
Key stats and ratios
| Q2 (Jun '17) | 2016 | |
| Net profit margin | 3.03% | 4.13% |
| Operating margin | 3.35% | 6.15% |
| EBITD margin | - | 11.86% |
| Return on average assets | 1.80% | 2.58% |
| Return on average equity | 2.40% | 3.37% |
| Employees | 1,541 |
No comments:
Post a Comment